GAMMAS
ActiveSummary
GAMMAS has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €1.3m and a net result of €149,631. Equity is growing by ~5.2% per year across the filed fiscal years. Its solvency ranks better than 61% of 19918 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability80▼-9
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €100,000 at 30 days acceptable
Liquidity ample (current ratio 4.34 against 5.89 in 2023; short-term debt: 22.8% and cash: 9.3% of total assets), and 23.7% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
76.3%
Return on assets
8.9%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 01-07-2025, 30 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
30 d early
2023
43 d early
2022
23 d late
2021
30 d late
2020
25 d late
2019
28 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 6 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
In the rankings
#10 company by equity in Nivelles, Health and social work sector
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€149,631▼ 42.8%
2023 · €261,779
Working capital
€1.3m▼ 3.7%
2023 · €1.3m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€165,808▼ 40.1%€157,313▼ 5.1%€273,309▲ 73.7%€364,372▲ 33.3%€210,876▼ 42.1%
Net result€125,548above the sector's middle half▼ 34.5%€114,318above the sector's middle half▼ 8.9%€194,823above the sector's middle half▲ 70.4%€261,779above the sector's middle half▲ 34.4%€149,631above the sector's middle half▼ 42.8%
Equity€1.1mabove the sector's middle half▲ 5.5%€1.0mabove the sector's middle half▼ 4.4%€1.1mabove the sector's middle half▲ 8.7%€1.3mabove the sector's middle half▲ 15.7%€1.3mabove the sector's middle half▼ 3.2%
Total assets€1.3mabove the sector's middle half▲ 9.8%€1.4mabove the sector's middle half▲ 6.4%€1.6mabove the sector's middle half▲ 15.5%€1.6mabove the sector's middle half▼ 0.2%€1.7mabove the sector's middle half▲ 4.6%
Debt€207,115▲ 40.6%€338,308▲ 63.3%€462,611▲ 36.7%€280,848▼ 39.3%€396,606▲ 41.2%
Working capital€1.1m▲ 6.8%€1.0m▼ 2.7%€1.1m▲ 9.3%€1.3m▲ 16.0%€1.3m▼ 3.7%
Solvency84.1%above the sector's middle half▼ 3.5pp75.6%within the sector's middle half▼ 8.5pp71.1%within the sector's middle half▼ 4.5pp82.4%within the sector's middle half▲ 11.3pp76.3%within the sector's middle half▼ 6.1pp
Staff (FTE)0.1below the sector's middle half▼ 80.0%0.5▲ 400%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 42% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.7m
Fixed assets
€18,343 ▲ 143%
Current assets
€1.7m ▲ 4.0%
Equity and liabilities €1.7m
Equity
€1.3m ▼ 3.2%
Debt
€396,606 ▲ 41.2%
Debt's share of the balance-sheet total rises from 17.6% to 23.7%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€211,188▼
2023 · €365,439
Cash flow
€149,943▼
2023 · €262,846
Current ratio
4.34▼
2023 · 5.89
Debt to equity
0.31▲
2023 · 0.21
ROE
11.7%▼
2023 · 19.9%
ROA
8.9%▼
2023 · 16.4%
Interest coverage
13.16▼
2023 · 33.40
Debt ≤ 1 year
€381,524▲
2023 · €270,101
Income taxes
€72,124▼
2023 · €123,651
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 20,129 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
4.7%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 20,129 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | - | €14,083 | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €15,005 | €15,536 | €2,309 | €1,067 | €312 | ▼ 70.7% |
| Other operating charges640/8 | - | €3,430 | €3,723 | €3,433 | €3,679 | ▲ 7.2% |
| Gross operating margin9900 | €208,289 | €190,362 | €279,342 | €368,872 | €214,867 | ▼ 41.8% |
| Operating profit (loss)9901 | €165,808 | €157,313 | €273,309 | €364,372 | €210,876 | ▼ 42.1% |
| Financial income75/76B | - | €21,265 | €24,312 | €31,999 | €26,922 | ▼ 15.9% |
| Recurring financial income75 | €16,824 | €21,265 | €24,312 | €31,999 | €26,922 | ▼ 15.9% |
| Financial charges65/66B | - | €7,639 | €8,861 | €10,941 | €16,044 | ▲ 46.6% |
| Recurring financial charges65 | €1,974 | €7,639 | €8,861 | €10,941 | €16,044 | ▲ 46.6% |
| Profit (loss) for the period before taxes9903 | €180,659 | €170,939 | €288,761 | €385,429 | €221,754 | ▼ 42.5% |
| Income taxes67/77 | €55,110 | €56,621 | €93,938 | €123,651 | €72,124 | ▼ 41.7% |
| Profit (loss) for the period9904 | €125,548 | €114,318 | €194,823 | €261,779 | €149,631 | ▼ 42.8% |
| Profit (loss) for the period to be appropriated9905 | €125,548 | €114,318 | €194,823 | €261,779 | €149,631 | ▼ 42.8% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.3m | €1.4m | €1.6m | €1.6m | €1.7m | ▲ 4.6% |
| Fixed assets21/28 | €26,469 | €10,933 | €8,624 | €7,556 | €18,343 | ▲ 143% |
| Tangible fixed assets22/27 | €26,413 | €10,877 | €8,567 | €7,500 | €18,287 | ▲ 144% |
| Furniture and vehicles24 | - | €10,877 | €8,567 | €7,500 | €8,287 | ▲ 10.5% |
| Other tangible fixed assets26 | - | - | - | - | €10,000 | - |
| Financial fixed assets28 | €56 | €56 | €56 | €56 | €56 | = |
| Current assets29/58 | €1.3m | €1.4m | €1.6m | €1.6m | €1.7m | ▲ 4.0% |
| Amounts receivable within one year40/41 | €29,532 | €10,034 | €11 | €1,959 | €25,467 | ▲ 1,200% |
| Trade receivables40 | - | €278 | €11 | €11 | €11 | = |
| Other amounts receivable41 | - | €9,756 | - | €1,948 | €25,456 | ▲ 1,206% |
| Current investments50/53 | €1.0m | €1.3m | €1.3m | €1.3m | €1.5m | ▲ 12.6% |
| Cash at bank and in hand54/58 | €219,190 | €57,505 | €285,267 | €271,627 | €156,146 | ▼ 42.5% |
| Deferred charges and accrued income490/1 | - | €537 | €464 | €10,713 | €837 | ▼ 92.2% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.3m | €1.4m | €1.6m | €1.6m | €1.7m | ▲ 4.6% |
| Equity10/15 | €1.1m | €1.0m | €1.1m | €1.3m | €1.3m | ▼ 3.2% |
| Contributions10/11 | - | €393,200 | €393,200 | €393,200 | €393,200 | = |
| Reserves13 | €702,645 | €654,260 | €745,314 | €924,567 | €882,565 | ▼ 4.5% |
| Non-distributable reserves130/1 | - | €40,559 | €40,559 | - | - | - |
| Reserves not available under the articles1311 | - | €40,559 | €40,559 | - | - | - |
| Distributable reserves133 | - | €613,701 | €704,755 | €924,567 | €882,565 | ▼ 4.5% |
| Amounts payable17/49 | €207,115 | €338,308 | €462,611 | €280,848 | €396,606 | ▲ 41.2% |
| Amounts payable within one year42/48 | €205,876 | €333,285 | €454,179 | €270,101 | €381,524 | ▲ 41.3% |
| Trade debts44 | €7,839 | €235 | €17,938 | - | €48 | - |
| Suppliers440/4 | - | €235 | €17,938 | - | €48 | - |
| Taxes, remuneration and social security45 | - | €14,608 | €20,244 | - | - | - |
| Taxes450/3 | - | €6,008 | €11,644 | - | - | - |
| Remuneration and social security454/9 | - | €8,600 | €8,600 | - | - | - |
| Other amounts payable47/48 | - | €318,441 | €415,996 | €270,101 | €381,476 | ▲ 41.2% |
| Accrued charges and deferred income492/3 | - | €5,024 | €8,432 | €10,747 | €15,082 | ▲ 40.3% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €125,548 | €114,318 | €194,823 | €261,779 | €149,631 | ▼ 42.8% |
| + Depreciation and write-downs630 | €15,005 | €15,536 | €2,309 | €1,067 | €312 | ▼ 70.7% |
| Operating cash flow (approximation) | €140,553 | €129,854 | €197,132 | €262,846 | €149,943 | ▼ 43.0% |
| Investment in fixed assets (approximation) | - | €0 | €0 | €0 | -€11,099 | - |
| Change in cash | - | -€161,686 | €227,762 | -€13,640 | -€115,480 | ▼ 747% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
01-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
18-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Highest result since 2018net €261,779 ▲34.4%
Operating result €364,372, net result €261,779, both a record.
23-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 23 days late
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
25-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 25 days late
2020
28-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 28 days late
2019
31-12
Financial
Equity above €1mEq €1.0m ▲9.3%
2 profitable years in a row build equity to €1.0m.
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 30 days late
2018
28-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 28 days late
2017
23-08
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 23 days late
2016
26-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Nivelles · 2 establishment units since 2009
Ground area
4,055 m²
Building footprint
466 m²
Volume, LiDAR
807 m³
2 parcels, Flanders, Wallonia · tallest building 9.0 m, ±2 floors. Linked by address, not a title deed.
6
companies at this address
See who is registered here
2 establishment units
GAMMAS
since 20092.175.237.272
Avenue de France 1, 1400 Nivelles
since 20152.247.955.895
2 parcels
Flanders
1
(50%)
Wallonia
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25072B0385/00P006 | Wallonia | 2,654 m² | 1 · 339 m² | - |
| 22002C0047/00D011 | Flanders | 1,401 m² | 1 · 127 m² | 9.0 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. De Meyer Tim - cardiologie
BE 0824.557.507
Nijlen · Eq €1,275,924
DR. KOENRAAD VAN RENTERGHEM UROLOOG
BE 0461.142.255
Zonhoven · Eq €1,276,365
PROSKINAB
BE 0547.929.838
Ham-sur-Heure-Nalinnes · Eq €1,275,145
DOKTER PEETERS HEIDI
BE 0876.197.337
Oudsbergen · Eq €1,274,992
TEMA
BE 0462.349.015
Anderlecht · Eq €1,277,313
Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 5,438 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded13-02-1997
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Contact
Phone
02/782 21 02Kraainem
E-invoicing
Reachable via Peppol
Peppol ID
0208:0460022104
Registered
06-11-2025
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.